Human trial

Multidisciplinary care reduces frailty in older cardiac patients

In a randomized trial, the year-long RENAP regimen yielded an adjusted mean difference of -0.79 in frailty and 2.02 in physical performance against usual care.

Nature Communications

In a multicentre trial of 333 frail inpatients aged 70 and older with cardiovascular diseases in Beijing, researchers tested the RENAP programme against usual care. The year-long intervention combined personalized rehabilitation exercises, patient education, nutritional guidance, acupoint massage, and polypharmacy management.

At 12 months, intention-to-treat analysis showed the intervention improved the Fried Frailty Phenotype score by an adjusted mean difference of -0.79 points and the Short Physical Performance Battery score by 2.02 points compared to usual care. Patients receiving the intervention also had a lower risk of all-cause hospital readmission over one year (hazard ratio 0.53). No treatment-related serious adverse events were reported.

Why it matters

Frailty represents a major manifestation of biological aging that exacerbates vulnerability and functional decline in older adults. Demonstrating that a coordinated, multi-target lifestyle and clinical protocol can improve physical performance indicates that frailty phenotypes remain modifiable even alongside serious cardiovascular disease.

Caveats

The study was conducted across three hospitals in a single city, and neither participants nor clinical teams could be blinded to the intervention. In addition, 81 of the 333 enrolled patients did not complete the 12-month primary outcome assessment.

The paper

Multidisciplinary intervention in frail elderly patients with cardiovascular diseases: a multicentre, single-blinded, randomised controlled trial

Chinese Academy of Medical Sciences & Peking Union Medical College

Nature Communications · 31 Aug 2026

doi.org/10.1038/s41467-026-77277-7PubMed 42811040